* Skylight Health Group Inc is expected to show a rise in quarterly revenue when it reports results on November 16. * The Mississauga Ontario-based company is expected to report a 49.8% increase in revenue to C$18.274 million from C$12.2 million a year ago, according to the mean estimate from 3 analysts, based on Refinitiv data. * Refinitiv's mean analyst estimate for Skylight Health Group Inc is for a loss of 15 cents per share. * The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." * The mean earnings estimate of analysts was unchanged in the last three months. * Wall Street's median 12-month price target for Skylight Health Group Inc is C$2, above its last closing price of C$0.65. Previous quarterly performance (using preferred earnings measure in Canadian dollars). QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI ENDING ARTESTIMAT IBES MET, SE % E® ESTIMATE MISSED Jun. 30 2022 -0.19 -0.19 -0.13 Beat 30.7 Mar. 31 2022 -0.19 -0.17 -0.21 Missed -23.5 Dec. 31 2021 -0.13 -0.12 -0.09 Beat 27.4 Sep. 30 2021 -0.09 -0.09 -0.09 Met -4.7 Jun. -0.06 -0.06 -0.11 Missed -91.3 30 2021 Mar. 31 2021 -0.08 -0.05 -0.06 Missed -20 Dec. 31 2020 0.00 -0.02 -0.30 Missed -1,701 .8 Sep. 30 2020 -0.05 -0.05 -0.05 Met 0 This summary was machine generated November 12 at 01:44 GMT. All figures in Canadian dollars unless otherwise stated.
